Mitochondria are essential organelles for most eukaryotic cells. They provide diverse metabolic functions including the production of energy and specialized metabolites for biosynthetic processes. To assemble functional mitochondria, proteins and RNAs encoded by both the mitochondrial and nuclear genomes are required. In humans, at least 1,000 nuclear encoded proteins are imported into mitochondria, whereas only 13 proteins of the electron transport chain are encoded by mitochondrial genes. The translation of these few but essential mitochondrial encoded proteins requires mitochondrial ribosomes, translation factors, and transfer RNAs, a subset of which must be imported from the cytosol into the mitochondrial matrix. Recent studies in evolutionarily diverse organisms have shown that multiple RNAs are encoded within the nucleus and imported from the cytosol into mitochondria. Our overall understanding of mitochondrial import pathways for nuclear encoded proteins is quite detailed. By contrast, very little is known about the mitochondrial import mechanism for nuclear encoded RNAs or how this new knowledge can be used to deliver specific RNAs into mitochondria. The revised overall goals of our competitive R01 renewal application are to dissect the main and perhaps only pathway of RNA import into mitochondria and to develop strategies that target nuclear encoded RNAs to mitochondria in reporter constructs and for the treatment of diseases caused by mutations of mitochondrial DNA (mtDNA). In separate studies, we will identify the cohort of RNAs that are imported into mitochondria using next generation RNA-Seq and coupled bioinformatics approaches. Previously, we reported studies that showed that the RNA processing enzyme polynucleotide phosphorylase (PNPase) is unexpectedly localized to the mitochondrial intermembrane space (IMS), where it functions as a gatekeeper for nuclear encoded RNAs that are imported from the cytosol. Interestingly, PNPase is only present in the genomes of organisms such as flies, worms, and mammals, suggesting that its functions are limited to higher eukaryotes. To accomplish our revised proposal goals that retain the original essence of the project, we have identified two specific study aims.
In Aim 1, additional regulatory components beyond PNPase for the import of nuclear encoded RNAs will be identified.
In Aim 2, reporter and corrective nuclear encoded RNA constructs will be engineered to determine the RNA sequence and structural requirements of the RNA import machinery and to develop strategies to treat diseases caused by mutations in mtDNA. For these studies we will take advantage of different model systems that we have established to manipulate PNPase levels and activities. In addition to increasing our fundamental knowledge about the mechanisms of RNA import into mitochondria and learning the rules for manipulating this RNA import pathway, our renewal application may have a broad impact on public health because our approach could provide a method to ameliorate or possibly cure dozens of human diseases caused by mtDNA mutations.

Public Health Relevance

This proposal is relevant to public health because it will provide fundamental new knowledge of the mechanisms and rules for importing nuclear encoded RNAs into mitochondria. Characterization and manipulation of this RNA import pathway will be beneficial for developing strategies to treat mitochondrial diseases caused by mutations in the mitochondrial genome. In addition, mutations in the RNA import pathway component PNPase are known to result in inherited deafness and neurodegenerative diseases, pointing to the importance of this import pathway and its components in human health and disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
2R01GM073981-09
Application #
8759910
Study Section
Neural Oxidative Metabolism and Death Study Section (NOMD)
Program Officer
Ainsztein, Alexandra M
Project Start
2006-01-01
Project End
2018-06-30
Budget Start
2014-08-04
Budget End
2015-06-30
Support Year
9
Fiscal Year
2014
Total Cost
$306,992
Indirect Cost
$102,930
Name
University of California Los Angeles
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Miyata, Non; Steffen, Janos; Johnson, Meghan E et al. (2014) Pharmacologic rescue of an enzyme-trafficking defect in primary hyperoxaluria 1. Proc Natl Acad Sci U S A 111:14406-11
Pate, Kira T; Stringari, Chiara; Sprowl-Tanio, Stephanie et al. (2014) Wnt signaling directs a metabolic program of glycolysis and angiogenesis in colon cancer. EMBO J 33:1454-73
Senese, S; Lo, Y C; Huang, D et al. (2014) Chemical dissection of the cell cycle: probes for cell biology and anti-cancer drug development. Cell Death Dis 5:e1462
TeSlaa, Tara; Teitell, Michael A (2014) Techniques to monitor glycolysis. Methods Enzymol 542:91-114
Levesque, Mitchell P; Krauss, Jana; Koehler, Carla et al. (2013) New tools for the identification of developmentally regulated enhancer regions in embryonic and adult zebrafish. Zebrafish 10:21-9
Dabir, Deepa V; Hasson, Samuel A; Setoguchi, Kiyoko et al. (2013) A small molecule inhibitor of redox-regulated protein translocation into mitochondria. Dev Cell 25:81-92
Wang, Geng; Shimada, Eriko; Zhang, Jin et al. (2012) Correcting human mitochondrial mutations with targeted RNA import. Proc Natl Acad Sci U S A 109:4840-5
Claypool, Steven M; Koehler, Carla M (2012) The complexity of cardiolipin in health and disease. Trends Biochem Sci 37:32-41
Sherman, Mara H; Bassing, Craig H; Teitell, Michael A (2011) Regulation of cell differentiation by the DNA damage response. Trends Cell Biol 21:312-9
Zhang, Jin; Khvorostov, Ivan; Hong, Jason S et al. (2011) UCP2 regulates energy metabolism and differentiation potential of human pluripotent stem cells. EMBO J 30:4860-73

Showing the most recent 10 out of 23 publications